Competitive Landscape
Established Brands Retain Leadership as Competitive Landscape Remains Stable
The Rx/reimbursement adult incontinence landscape remains highly concentrated, with established medical brands continuing to secure the vast majority of product usage and prescription volumes. There was no evidence of significant shifts in concentration or fragmentation over the review period, with the leading positions of top brands maintained through consistent adherence to clinically proven standards and regulatory requirements.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Estonia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Estonia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Estonia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Estonia?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Estonia?
- How are products distributed in Rx/Reimbursement adult incontinence in Estonia?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Estonia - Category analysis
Key Data Insights
Tena and Molicare Secure High Usage with Clinically Proven Essentials
Tena and Molicare Secure High Usage with Clinically Proven Essentials
Procurement Bodies Favour Clean Wellness with Medicalised Product Features
Physicians to Drive Demand for Clinically Validated Essentials as Reimbursement Rules Shape Choices
Suppliers Prioritise Clinical Outcomes and Affordability as Innovation Focuses on Practical Improvements
Demographic Shifts and Steady Expenditure Will Support Future Resilience in Reimbursed Incontinence
Established Brands Retain Leadership as Competitive Landscape Remains Stable
Procurement Authorities Maintain Offline Channels as Primary Access Point
Tissue and Hygiene in Estonia - Industry Overview
Rimi Expands Affordable Tissue Range and Attracts Price-Conscious Shoppers
Key Data Insights
Rimi Expands Affordable Tissue Range and Attracts Price-Conscious Shoppers
Recycled Tissue with Ecolabel Certification Reshapes Everyday Choices
Pants-Style Hygiene Products Redefine Convenience for Active Lifestyles
Private Label Expands Affordable Bulk Packs as Value Drives Purchases
Convenience Formats and Home Delivery Reshape Daily Routines
Sustainable and Skin-Friendly Innovations Challenge Ultra-Cheap Basics
Private Label Gains Ground as Established Leaders Defend Share
Supermarkets Extend Lead with Strong Private Label and Promotions
Retail E-Commerce Gains Traction as Shoppers Prioritise Convenience
Discounters and E-Commerce Reshape Price and Convenience Dynamics
Country Reports Disclaimer
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!